Treatment Options For Non-Small Cell Lung Cancer

Immunotherapy

Immunotherapy is a newer treatment for non-small cell lung cancer. It employs the patient’s immune system to find and fight cancerous cells. Research has made this treatment an effective one as the immune system is quite adaptable. For instance, checkpoint inhibitors in immunotherapy stop cancerous cells because they turn off the checks and balances part of the immune system that is compromised in cancer patients.

Additionally, monoclonal antibodies use artificial antibodies that are designed to target cancerous cells and attack them. This is similar to the natural antibodies of the immune system. Another form of immunotherapy removes immune T-cells and alters them in a lab before they are put back into the patient’s body to kill cancerous cells.